Framingham Cardiovascular Risk Profile Correlates with Impaired Hippocampal and Cortical Vasoreactivity to Hypercapnia
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Vascular risk factors affect cerebral blood flow ( CBF) and cerebral vascular reactivity, contributing to cognitive decline. Hippocampus is vulnerable to both Alzheimer's disease (AD) pathology and ischemia; nonetheless, the information about the impact of vascular risk on hippocampal perfusion is minimal. Cognitively, healthy elderly (NL = 18, 69.9 ± 6.7 years) and subjects with mild cognitive impairment (MCI = 15, 74.9 ± 8.1 years) were evaluated for the Framingham cardiovascular risk profile ( FCRP). All underwent structural imaging and resting CBF assessment with arterial spin labeling (ASL) at 3T magnetic resonance imaging (MRI). In 24 subjects (NL = 17, MCI = 7), CBF was measured after a carbon dioxide rebreathing challenge. Across all subjects, FCRP negatively correlated with hippocampal (ρ = −0.41, P = 0.049) and global cortical (ρ = −0.46, P = 0.02) vasoreactivity to hypercapnia ( VR h). The FCRP– VR h relationships were most pronounced in the MCI group: hippocampus (ρ = 0.77, P = 0.04); global cortex (ρ = 0.83, P = 0.02). The FCRP did not correlate with either volume or resting CBF. The hippocampal VR h was lower in MCI than in NL subjects ( Z = −2.0, P = 0.047). This difference persisted after age and FCRP correction (F[3,20] = 4.6, P = 0.05). An elevated risk for vascular pathology is associated with a reduced response to hypercapnia in both hippocampal and cortical tissue. The VR h is more sensitive to vascular burden than either resting CBF or brain volume.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eichenbaum (2004) · doi:10.1016/j.neuron.2004.08.028 · Cited by 1,464
T1, T2 relaxation and magnetization transfer in tissue at 3T
Stanisz, G. J., Odrobina, E. E., Pun, J., Escaravage, M., Graham, S. J., Bronskill, M. J., & Henkelman, R. M. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20605 · Cited by 1,266
Preclinical prediction of Alzheimer's disease using SPECT
Johnson, K. A., Jones, K., Holman, B. L., Becker, J. A., Spiers, P. A., Satlin, A., & Albert, M. S. (1998) · Neurology · doi:10.1212/wnl.50.6.1563 · Cited by 471 · cited 1×
“Furthermore, both CBF reduction (Hirao et al, 2005; Caroli et al, 2007; Hansson et al, 2009; Johnson et al, 1998; Kitagawa et al, 2009; Chao et al, 2010) and deficits in the reactivity of cerebral vessels to hypercapnia (vasoreactivity to hypercapnia (VRh)) forecast cognitive decline (Silvestrini…”
BackgroundSpecific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease
Convit, A., De Leon, M. J., Tarshish, C., De Santi, S., Tsui, W., Rusinek, H., & George, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00001-8 · Cited by 427 · cited 2×
“Left and right hippocampus were manually outlined on reformatted coronal MPRAGE images (Convit et al, 1997).”
MethodSelf-citationCorrelates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia
Zarow, C., Vinters, H. V., Ellis, W. G., Weiner, M. W., Mungas, D., White, L., & Chui, H. C. (2005) · Annals of Neurology · doi:10.1002/ana.20503 · Cited by 241 · cited 1×
“As hippocampal cornu ammonis sector1 is highly sensitive to both AD pathology and ischemia (Zarow et al, 2005), the presence of vascular risk can strongly compound on AD-related damage.”
BackgroundCerebral vasomotor reactivity and cerebral white matter lesions in the elderly
Bakker, S. L. M., de Leeuw, F.-E., de Groot, J. C., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.52.3.578 · Cited by 207
Cited by
Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
“[37] Glodzik L, Rusinek H, Brys M, Tsui WH, Switalski R, Mosconi L,”
BackgroundMeasuring cerebrovascular reactivity: what stimulus to use?
Fierstra, J., Sobczyk, O., Battisti‐Charbonney, A., Mandell, D. M., Poublanc, J., Crawley, A. P., Mikulis, D. J., Duffin, J., & Fisher, J. A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.259150 · Cited by 318
Cerebral Hemodynamics and Vascular Risk Factors: Setting the Stage for Alzheimer's Disease
de la Torre, J. C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120793 · Cited by 219
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease
Hays, C. C., Zlatar, Z. Z., & Wierenga, C. E. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0261-z · Cited by 213
“…et al. 2010), cognitive decline (Pfefferkorn et al. 2001; Silvestrini et al. 2006; Vicenzini et al. 2007; Cantin et al. 2011; Zavoreo et al. 2013), and is more sensitive to vascular burden as measured by the Framingham Stroke Risk Profile than resting CBF or brain volume (Glodzik et al. 2011).”
MethodVarga, A. W., Wohlleber, M. E., Giménez, S., Romero, S., Alonso, J. F., Ducca, E. L., Kam, K., Lewis, C., Tanzi, E. B., Tweardy, S., et al. (2016) · SLEEP · doi:10.5665/sleep.6240 · Cited by 203
Self-citationWolk (2012) · doi:10.1097/wco.0b013e328354ff0a · Cited by 147
Do, T. M., Alata, W., Dodacki, A., Traversy, M.-T., Chacun, H., Pradier, L., Scherrmann, J.-M., Farinotti, R., Calon, F., & Bourasset, F. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.010 · Cited by 77
Papma, J. M., den Heijer, T., de Koning, I., Mattace-Raso, F. U., van der Lugt, A., van der Lijn, F., van Swieten, J. C., Koudstaal, P. J., Smits, M., & Prins, N. D. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2012.11.005 · Cited by 48
Metadata
- Authors
- Glodzik, L., Rusinek, H., Brys, M., Tsui, W. H., Switalski, R., Mosconi, L., Mistur, R., Pirraglia, E., de Santi, S., Li, Y., Goldowsky, A., & de Leon, M. J.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2010-09-15
- Volume
- 31
- Issue
- 2
- Pages
- 671-679
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2034337851
- Cited by
- 73
- References
- 6
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.